Modulation of rat brain synaptosomal plasma membrane achieved by atracurium and its metabolite laudanosine

Intensive Care Medicine

Volumn 24, Issue 5, 1998, Pages 519-525

  Kamper, E F ^a   Siafaka, J ^b   Stavridis, J ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

Atracurium besylate; Laudanosine; Modulation of lipid protein interaction; Neurotoxicity; Synaptosomal plasma membrane bound enzymes

Indexed keywords

5' NUCLEOTIDASE; ADENOSINE TRIPHOSPHATASE (MAGNESIUM); ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ATRACURIUM BESILATE; DRUG METABOLITE; FLUORIDE; LAUDANOSINE; MEMBRANE LIPID; MUSCLE RELAXANT AGENT;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN SYNAPTOSOME; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; DRUG METABOLISM; ENZYME ACTIVITY; ENZYME INHIBITION; LIPID BRAIN LEVEL; MALE; NERVE CELL; NEUROTOXICITY; NONHUMAN; PROTEIN LIPID INTERACTION; RAT; SEIZURE; SYNAPTIC MEMBRANE; TEMPERATURE SENSITIVITY;

5'-NUCLEOTIDASE; ANIMALS; ATRACURIUM; BRAIN; CA(2+) MG(2+)-ATPASE; CELL MEMBRANE; CENTRAL NERVOUS SYSTEM AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ISOQUINOLINES; MALE; NA(+)-K(+)-EXCHANGING ATPASE; NEUROMUSCULAR DEPOLARIZING AGENTS; RATS; RATS, WISTAR; SYNAPTOSOMES;

EID: 0031776169     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001340050605     Document Type: Article

References (35)

1. Basta SJ, Ali HH, Savarese JJ, et al (1982) Clinical pharmacology of atracurium besylate (BW 33 A): a new non-depolarizing muscle relaxant. Anesth Analg 61: 723-729
2. Stenlake JB, Waigh RD, Urwin J, Dewar GH, Coker GG (1983) Atracurium: conception and inception. Br J Anaesth 55 (S 1): 3 S-10 S
3. Stiller RL, Ryan Cook D, Chakravorti S (1985) In vitro degradation of atracurium in human plasma. Br J Anaesth 57: 1085-1088
4. Pollard BJ (1993) Neuromuscular blocking agents in intensive care. Intensive Care Med 19: S 36-S 39
5. Yate PM, Flynn PJ, Arnold RW, Weatherly BC, Simmonds RJ, Dopson T (1987) Clinical experience and plasma laudanosine concentrations during the infusion of atracurium in the intensive therapy unit. Br J Anaesth 59: 211-217
6. Parker CJR, Jones JE, Hunter JM (1988) Disposition of infusion of atracurium and its metabolite, laudanosine, in patients in renal and respiratory failure in an ITU. Br J Anaesth 61: 531-540
7. Chapple DJ, Miller AJ, Ward JB, Wheatley PL (1987) Cardiovascular and neurological effects of laudanosine. Studies in mice and rats and in conscious and anaesthetised dogs. Br J Anaesth 58: 218-255
8. Migrovic V, Fox JL (1991) Atracurium decay and the formation of laudanosine in humans. Anesthesiology 74 (3): 446-454
9. Hughes R (1986) Atracurium: an overview. Br J Anaesth 58: 2 S-5 S
10. Dipple I, Gordon LM, Houslay MD (1982) The activity of 5 nucleotidase in liver plasma membranes is affected by the increase in bilayer fluidity achieved by anionic but not cationic drugs. J Biol Chem 257: 1811-1815
11. Deliconstantinos G, Kopeikina-Tsiboukidou L, Viliotou V (1987) Evaluation of membrane fluidity effects and enzyme activities alterations in adriamycin neurotoxicity. Biochem Pharmacol 36: 1153-1161
12. Gordon LM, Sauerheber RD, Esgate JA, Dipple I, Marchmont RJ, Houslay MD (1980) The increase in bilayer fluidity of rat liver plasma membranes achieved by the local anesthetic benzyl alcohol affects the activity of intrinsic membrane enzymes. J Biol Chem 255: 4519-4527.
13. Houslay MD, Dipple I, Gordon LM (1981) Phenobarbital selectively modulates the glucagon-stimulated activity of adenylate cyclase by depressing the lipid phase separation occurring in the outer half of the bilayer of liver plasma membrane. Biochem J 197: 675-681
14. Al-Muhandis WM, Lauretti GR, Pleury BJ (1991) Modification by drugs used in anaesthesia of CNS stimulation induced in mice by laudanosine and strychnine. Br J Anaesth 67: 608-613
15. Papaphilis A, Deliconstantinos G (1980) Modulation of serotonergic receptors by exogenous cholesterol in the dog synaptosomal plasma membrane. Biochem Pharmacol 29: 3325-3327
16. Masters BSS, Williams CH Jr, Kamin H (1967) The preparation and properties of microsomal TPNH-cytochrome C reductase from pig liver. Methods Enzymol 10: 565-573
17. Houslay MD, Tipton KF (1973) The reaction pathway of membrane-bound rat liver mitochondrial monoamine oxidase. Biochem J 135: 735-750
18. Lowry DH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193: 26 S-27 S
19. Fiske CH, Subbarow Y (1925) Colorimetric determination of inorganic phosphorus. J Biol Chem 66: 375-400
20. Bodansky O, Schwartz MK (1963) Comparative effects of L-histidine on the activity of 5′-nucleotidase and alkaline phosphatase. J Biol Chem 238: 3420-3427
21. Deliconstantinos G, Tsakiris S (1985) Differential effect of anionic and cationic drugs on the synaptosomal-associated acetylcholinesterase activity of dog brain. Biochem J 229: 81-86
22. Farias RN (1980) Membrane cooperative enzymes as a tool for the investigation of membrane structure and related phenomena. Adv Lipid Res 17: 251-282
23. Davis DG, Inesi G, Gulik-Krzywicki T (1976) Lipid molecular motion and enzyme activity in sarcoplasmic reticulum membrane. Biochemistry 15: 1271-1276
24. +)-stimulated adenosine triphosphatase. J Biol Chem 249: 1071-1080
25. Sineriz F, Farias RN, Trucco RE (1974) The convenience of the use of allosteric "probes" for the study of lipid-protein interactions in biological membranes: thermodynamic considerations. J Theor Biol 52: 113-120
26. Kopeikina L, Degiannis E, Villiotou V, Stavridis J (1997) Calmodulin-related changes in microsomal membrane fluidity during liver regeneration. J Surg Res 67: 155-162
27. Szenohradszky J, Trevor A, Bickler P, et al (1993) Central nervous system effects of intrathecal muscle relaxants in awake rats. Anesth Analg 76: 1304-1309
28. Spinedi A, Luly P, Farias RN (1993) Does the fluidity of the lipid environment modulate membrane-bound acetylcholinesterase? Effects of temperature, membrane composition and amphiphile. Biochem Pharmacol 46: 1521-1527
29. Deliconstantinos G, Kopeikina-Tsiboukidou L, Villiotou V (1987) Evaluation of membrane fluidity effects and enzyme activities alterations in adriamycin neurotoxicity. Biochem Pharmacol 36 (7): 1153-1161
30. Fahey MR, Claver Canfell P, Taboada T, Ho Sobuchi Y, Miller RD (1990) Cerebrospinal fluid concentrations of laudanosine after administration of atracurium. Br J Anaesth 64: 105-106
31. Eddleston JM, Harper NJN, Pollard BJ, Edwards D, Gwinnutt CI (1989) Concentrations of atracurium and laudanosine in cerebrospinal fluid and plasma during intracranial surgery. Br J Anaesth 63: 525-530
32. Woolf NJ, Butcher LL (1989) Cholinergic systems: synopsis of anatomy and overview of physiology and pathology. In: Scheibel AB, Wechsler AF (eds) The biological substrates of Alzheimer's disease. Academic Press, New York, pp 73-86
33. Simon R, Atweh S, Kuhar MJ (1976) Sodium-dependent high affinity choline uptake. A regulatory step in the synthesis of acetylcholine. J Neurochem 26: 909-922
34. Jones OT, McNamee KK (1988) Annular and non-annular binding sites for cholesterol associated with the nicotinic acetylcholine receptor. Biochemistry 27: 2364-2374
35. Fong TM, McNamee MG (1986) Correlation between acetylcholine receptor function and structural properties of membranes. Biochemistry 25: 830-840